CORE EARNINGS PER SHARE: Core earnings per share are expected to rise to $2.07 from $1.45 the year prior, according to the same consensus. AstraZeneca's stock is up 7.9% since the start of 2024.
Google parent Alphabet is slated to report its fourth-quarter results after the market closes Tuesday, with analysts mostly bullish on the tech giant's stock.